西CT-P47西:,,I

Kyung-Sang Yu1, Byungwook Kim1, Dongseong Shin2

  • 1Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.

概括

托西利祖马布生物类似剂CT-P47在健康的亚洲成年人中证明了与欧盟托西利祖马布的药理学等价性. 这一发现支持CT-P47作为需要托西利祖马布治疗的患者的可比替代品.